Research & Publications
Nox Medical’s PSG system, The Nox A1 was included in a study that was recently published in the Journal of Clinical Sleep Medicine. The study’s intention was to test the feasibility of ambulatory polysomnography (PSG-home) in a group of children suspected of obstructive sleep apnea (OSA).
Company Updates
With the dual-purpose, diagnostic sleep device, Nox A1, sleep medicine clinicians no longer have to decide between investing in polysomnogram (PSG) systems and home sleep tests (HST). The Nox A1, launched in 2014, can serve both of these purposes, all in a small package.
Company Updates
Earlier this year, Nox Medical launched its innovative polysomnographic system, The Nox A1 PSG System in the United States and Canada. In their Sleeplab Magazine May issue, RT SleepWorld covers the product launch and interviews Pétur Már Halldórsson, CEO of Nox Medical on the future of sleep medicine.
Company Updates
Nox Medical sleep systems are thoughtfully designed for safe and hygienic operation, while providing high signal quality. The Nox Cannula and Nox RIP belts are single patient use only, reducing the risk of cross-infection and possible cross contamination if handled properly.
Company Updates
Nox Medical has officially launched its innovative polysomnographic system, the Nox A1, in the U.S. and Canada. The Nox A1 is a powerful, ambulatory PSG device that combines thoughtful design with clinical accuracy, allowing sleep labs to maximize their investment…
Company Updates
Starting today, October 1st 2019, Nox products are sold and supported directly by Nox Medical USA. Distribution relationships for other markets will remain the same. The Nox T3, associated consumables, and support was previously provided by Vyaire Medical in the United…
Company Updates
Nox Medical is happy to announce that the company has signed onto a partnership with Brojaw for distributing Nox sleep systems in Taiwan.
